Jaguar Health/$JAGX
1D1W1MYTD1Y5YMAX
Capital at risk
About Jaguar Health
Jaguar Health Inc is a commercial-stage pharmaceutical company developing novel proprietary prescription medicines sustainably derived from plants from rainforest areas for gastrointestinal disease states in humans and animals. The Company focuses on conditions associated with overactive bowel, including chronic debilitating diarrhea, urgency, and bowel incontinence. It operates through two segments: animal health, which develops and commercializes products for animals, and human health, with the human health segment generating the maximum revenue and focusing on products such as Mytesi, focusing on human products, specifically Mytesi, approved for symptomatic relief of non-infectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.
- Ticker
- $JAGX
- Sector
- Health
- Primary listing
- NASDAQ
- Employees
- 47
- Headquarters
- San Francisco, United States
- Website
- jaguar.health
Jaguar Health Metrics
BasicAdvanced
$934K
-
-$2,338.09
-0.06
-
Price and volume
Market cap
$934K
Beta
-0.06
52-week high
$3.70
52-week low
$2.35
Financial strength
Current ratio
0.739
Quick ratio
0.168
Long term debt to equity
0.395
Total debt to equity
2.533
Interest coverage (TTM)
-25.15%
Profitability
EBITDA (TTM)
-23.193
Gross margin (TTM)
82.31%
Net profit margin (TTM)
-130.85%
Operating margin (TTM)
-90.22%
Revenue per employee (TTM)
$590,000
Management effectiveness
Return on assets (TTM)
-38.04%
Return on equity (TTM)
-548.83%
Valuation
Price to revenue (TTM)
0.002
Price to book
0.13
Price to tangible book (TTM)
-0.1
Price to free cash flow (TTM)
-0.009
Free cash flow yield (TTM)
-11,074.20%
Free cash flow per share (TTM)
-300
Growth
Revenue change (TTM)
135.52%
3-year revenue growth (CAGR)
36.00%
Upcoming events
No upcoming events
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real-time US market data is sourced from the IEX order book provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.